Overseas IVF Country Comparison: Differences Among Thailand, USA, Malaysia, Japan and 7 Countries

Opening: Real Consultation Scenario

Consultation Scenario — A 38-year-old woman, AMH 0.9 ng/mL, FSH 11.2 IU/L, with one previous IVF failure. She wants to know which of Thailand, the USA, and Malaysia is more suitable for her age and ovarian reserve. She has consulted several agencies and received different recommendations but lacks objective comparison.

Overseas IVF Country Comparison: Where Are the Core Differences?

Choosing an overseas IVF country is not simply about good or bad, but about matching. Matching dimensions include: legal policies (can PGT, egg donation, surrogacy be performed), medical technology and laboratory standards, total cost structure, cycle timing, and the ability to handle specific conditions (e.g., advanced age, low ovarian reserve, recurrent implantation failure, genetic diseases).

Among the current mainstream overseas IVF destinations, the USA, Thailand, Malaysia, Japan, Cambodia, Georgia, and Greece are the most representative. The following is a horizontal comparison from six core dimensions.

Horizontal Comparison of Seven Countries Across Core Dimensions

Note: Live birth rate reference data comes from annual reports of national reproductive medicine societies and public literature. Individual differences are significant and do not constitute a commitment from any medical institution.

Cost Composition and Influencing Factors

The cost of overseas IVF is not a single number but is composed of the following parts:

• Medical fees: ovulation induction drugs, egg retrieval surgery, embryo culture, PGT testing, transfer surgery, etc. The USA has the highest medical costs, while Southeast Asian countries are relatively low.
• Laboratory fees: embryo culture environment, time-lapse imaging, genetic testing, etc. Labs with CLIA certification or equivalent standards cost more.
• Third-party assistance fees: If egg donation, sperm donation, or surrogacy is needed, costs increase significantly. Surrogacy in the USA costs about $100,000–$200,000, while in Georgia it is about $40,000–$60,000.
• Travel and living expenses: visa, airfare, accommodation, translation, local transportation, etc. The cycle usually requires 14–21 days of overseas stay.
• Agency and service fees: Some agencies charge coordination fees, translation fees, legal consultation fees, etc., accounting for about 10%–20%.

The core reasons for cost differences are: legal compliance costs, laboratory construction standards, medical staff salary levels, and the legality and regulatory intensity of third-party assistance. The high cost in the USA is backed by strict quality supervision and legal protection; the low cost in Southeast Asia corresponds to lower operating costs, but lab standards and regulatory oversight vary.

IVF Cycle Timeline by Country

From initial consultation to transfer completion, overseas IVF usually involves the following stages. Timelines are roughly similar across countries, but details differ:

• Preparation (1–3 months): Complete fertility assessment for both partners (AMH, FSH, antral follicle count, semen analysis, karyotype, infectious disease screening), passport application (validity must cover the entire cycle), visa application, medical record translation and notarization.
• Cycle start and stimulation (10–14 days): Start ovulation induction on day 2–3 of menstruation, with monitoring of follicle development and hormone levels. Thailand, Malaysia, and Cambodia offer flexible scheduling; Japan requires stricter cycle control.
• Egg retrieval and embryo culture (3–6 days): Egg retrieval is performed on the day of surgery, and embryos are cultured to the blastocyst stage on day 5–6. If PGT is needed, wait an additional 2–4 weeks for results.
• Transfer and luteal support (1–2 days): Transfer is usually performed on day 18–22 of the menstrual cycle, followed by luteal support for 12–14 days.
• Pregnancy test and follow-up: Blood test for HCG 12–14 days after transfer. If frozen embryo transfer is needed, it can be spaced 1–3 menstrual cycles apart.

How far in advance should you prepare?: It is recommended to start preliminary checks at least 3 months in advance. Those with low AMH or advanced age should allow more time for physical conditioning and plan evaluation.

Easiest Details to Overlook

Passport and Visa Requirements

Passport validity must cover the entire overseas stay; most countries require a passport valid for at least 6 months. Thailand and Malaysia offer visa-free or visa-on-arrival for Chinese citizens, but the stay is limited; the USA, Japan, and Greece require a medical visa application in advance, taking about 2–6 weeks.

Medical Record Translation and Notarization

Domestic reports (vaginal ultrasound, hormone panel, semen analysis, chromosome reports, etc.) need to be translated into English or the target country's language by a professional medical translation agency and notarized. Some countries require the issuing institution to have appropriate qualifications; otherwise, tests may need to be repeated.

Impact of Time Zone Differences on Communication

When conducting remote consultations with overseas doctors, time zone differences may affect communication efficiency. It is recommended to confirm the working hours of the medical institution's international coordination staff in advance to avoid delays in critical information.

Medication Timing Adjustments

After cross-border flights, hormone levels and circadian rhythms may be affected by jet lag. Medication timing during the cycle must be strictly followed as per the doctor's instructions and should not be adjusted independently.

Common Pitfalls

• Overpromising by agencies: Some agencies use slogans like "guaranteed success" or "100% live birth," which go against medical norms. No legitimate medical institution can guarantee success.
• Hidden costs: Quotes may not include PGT testing fees, medication costs, translation fees, legal consultation fees, etc., leading to total costs far exceeding expectations. Request a complete fee breakdown before signing.
• Variation in lab standards: Even within the same country, lab standards at different reproductive centers vary significantly. For example, Thailand has both internationally certified labs and clinics with outdated equipment. Verify lab certifications (e.g., ISO 15189, CAP, CLIA).
• Generational gap in PGT technology: PGT-A, PGT-SR, and PGT-M have different lab requirements. Some centers only offer basic PGT-A and cannot handle balanced translocations or single-gene disorders. Confirm the technical scope based on your situation.
• Legal risks: Operating in countries with ambiguous surrogacy or egg donation policies may later face issues with parentage determination, entry/exit, or nationality. Always confirm compliance through local legal channels.

Reproductive Doctor's Perspective: Country Selection Based on Medical Indications

From a clinical decision-making perspective, country selection should prioritize the following medical factors:

• Advanced age (≥38) or low ovarian reserve (AMH <1.1 ng/mL): Requires a lab with mature oocyte activation, blastocyst culture, and PGT technology. Labs in the USA and Greece have more experience with minimal sperm processing and oocyte activation.
• Recurrent implantation failure (RIF): Requires comprehensive diagnostic capabilities such as ERA (endometrial receptivity analysis), immunological evaluation, and hysteroscopy. Some top centers in the USA, Japan, and Thailand offer complete RIF assessment packages.
• Genetic diseases or chromosomal abnormalities: Must choose a country where PGT-M or PGT-SR technology is mature and legally allowed. The USA, Greece, and Malaysia (non-Muslim) have more experience with single-gene disorder PGT.
• Need for egg donation or surrogacy: Must choose a country where it is legally clear and well-regulated. Georgia and the USA (some states) have relatively clear legal frameworks; Cambodia, while lenient, has higher legal and medical risks.
• Polycystic ovary syndrome or abnormal follicle development: Requires individualized stimulation protocols and close monitoring. Some centers in Japan and Thailand have extensive experience in follicle development regulation.

Suitable and Unsuitable Populations for Each Country

USA

Suitable for: Those with ample budget (total cost over 300,000 RMB), need surrogacy or egg donation, have genetic diseases requiring PGT-M, or have recurrent implantation failure needing high-end lab evaluation.
Unsuitable for: Those with limited budget, tight cycle schedule, no need for third-party assistance, and high cost-effectiveness requirements.

Thailand

Suitable for: Those with moderate budget (80,000–150,000 RMB), no need for surrogacy, wish to do PGT, and are under 40 with adequate ovarian function. Thailand has some experience with advanced maternal age IVF and low AMH, but certified labs should be selected.
Unsuitable for: Those needing egg donation or surrogacy, or requiring extremely high lab certification standards.

Malaysia

Suitable for: Couples with moderate budget, convenient English communication, stable policies, and no need for surrogacy. Egg donation is legal for non-Muslims in Malaysia, suitable for those needing egg sources.
Unsuitable for: Muslim couples or those needing surrogacy.

Japan

Suitable for: Those who value refined medical care, have adequate ovarian function, do not need PGT or have simple PGT needs, and are willing to accept stricter cycle control. Japan has good live birth rates for younger women with normal ovarian reserve.
Unsuitable for: Those with severely low ovarian reserve (AMH <0.5), needing PGT-M or surrogacy.

Cambodia

Suitable for: Those with very limited budget, need lenient policies (egg donation/surrogacy), are not sensitive to lab standards, and are willing to take higher medical risks.
Unsuitable for: Those with high requirements for lab certification, medical safety, and legal protection.

Georgia

Suitable for: Those needing legal surrogacy with a moderate budget (total cost 100,000–150,000 RMB) and wish to operate within a European regulatory framework. Georgia clearly allows surrogacy by law, and costs are much lower than in the USA.
Unsuitable for: Those with strict requirements for top-tier lab standards or needing complex PGT-M technology.

Greece

Suitable for: Those with a moderate to high budget (90,000–160,000 RMB), need PGT and wish to benefit from European reproductive medicine standards, and do not need surrogacy. Greece has mature applications of PGT-A and PGT-M technology.
Unsuitable for: Those needing surrogacy or with extremely limited budget.

Common Preparation Questions for Overseas IVF

The following questions appear frequently in knowledge base consultations. Here are centralized answers:

• When should overseas IVF tests be done? It is recommended to complete them 3 months before the planned start. AMH, FSH, and antral follicle count (AFC) should be checked on days 2–4 of menstruation; semen analysis requires 2–7 days of abstinence; chromosome and infectious disease tests have no time restrictions, but some tests (e.g., hysteroscopy) should avoid menstruation.
• How far in advance should I prepare for overseas IVF? A full cycle from initial consultation to transfer usually takes 4–6 months, including preliminary checks, visa processing, medical coordination, cycle stimulation, embryo culture, and transfer. Those with low AMH or advanced age should allow an extra 1–2 months for physical conditioning.
• What are the passport validity requirements for overseas IVF? Most countries require the passport to be valid for the entire overseas stay and at least 6 months. In some countries (e.g., the USA), visa validity is tied to the passport; if the passport expires, a new visa is needed.
• What materials are needed for overseas IVF registration? Both partners' ID cards, passports, marriage certificate (notarized translation required in some countries), previous medical records, original test reports and translations, and visa page copies.
• Male partner's test items for overseas IVF: Semen analysis (routine + morphology + DNA fragmentation), infectious disease screening (HIV, hepatitis B, hepatitis C, syphilis), karyotype, Y chromosome microdeletion (if necessary).
• Female partner's test items for overseas IVF: AMH, sex hormone panel (days 2–4 of menstruation), vaginal ultrasound (antral follicle count), thyroid function, infectious disease screening, karyotype, hysteroscopy (if necessary).
• Can I still do overseas IVF with low AMH? Yes. Low AMH does not mean no eggs, but the number of eggs retrieved will be reduced. It is recommended to choose centers with experience in handling minimal oocytes (e.g., some institutions in the USA, Japan, and Greece) and be mentally prepared for possibly needing multiple cycles to accumulate embryos.
• What should I prepare for overseas IVF at an advanced age? Focus on evaluating ovarian reserve, uterine environment, metabolic status, and genetic risks. It is recommended to complete metabolic indicators such as glucose tolerance, thyroid function, vitamin D, and homocysteine, and adjust for 2–3 months before starting the cycle.
• Do I need to condition before overseas IVF? Yes. Adjust lifestyle at least 1–3 months in advance: regular routine, balanced nutrition (increase high-quality protein and antioxidant foods), folic acid supplementation (female), weight control (BMI ≤ 24), smoking cessation and alcohol limitation. Male partners should avoid high-temperature environments and supplement zinc, selenium, and other trace elements.

Practitioner's Observation: Ten Years of Overseas Coordination Experience

Having worked in overseas assisted reproduction coordination for ten years and interacted with thousands of families, one phenomenon is worth noting: Many people equate "country selection" with "success rate selection," ignoring individual medical evaluation and actual lab standards. Within the same country, IVF live birth rates at different reproductive centers can differ by more than 20 percentage points. Therefore, choosing a country is only the first step; selecting the right specific reproductive center and lab is key.

Additionally, the stability of legal policies needs careful consideration. In 2015, Thailand's policy changed abruptly, forcing many families undergoing surrogacy to stop. Choosing countries with ambiguous or frequently changing policies means additional legal and financial risks. It is recommended to verify the latest regulations of the target country through independent legal channels before making a decision, rather than relying solely on information from agencies or institutions.

Finally, communication quality directly affects medical safety. Medication errors, time delays, and protocol misunderstandings due to language barriers are not uncommon in cross-border medical care. Prioritizing centers with Chinese medical coordinators or international patient service teams can significantly reduce communication risks.